Digital Clinic

What Digital Clinic does

Digital Clinic is an India-based AI healthtech company founded in 2017 and headquartered in Hyderabad that develops OncoVision (also branded DC-OncoVision), an AI workflow platform for breast cancer diagnostics and grading. The platform processes digitized histopathology slides, mammography, and ultrasound images alongside structured clinical biomarker data to perform automated Nottingham grading (a registered/granted patent in India), BI-RADS screening, and biomarker identification directly from routine histology slides — the latter positioned as a substitute for costly and time-consuming NGS testing. OncoVision also produces predictive outputs, specifically Pathological Complete Response predictions used to assess Neoadjuvant Chemotherapy suitability, and aligns its workflows with College of American Pathologists (CAP) standards for integration into first-line precision oncology. Complementary diagnostic modules cover metastatic breast cancer (sentinel lymph node metastasis) and AI-augmented annual ultrasound and mammography checkups.

The company's revenue model is subscription-based licensing of the OncoVision platform, supplemented by precision oncology services that deliver AI-driven targeted therapy recommendations through biomarker identification. Go-to-market is sales-led and entirely direct to enterprise and mid-market buyers — primarily hospitals, diagnostic centres, and medical colleges in India — via demo requests, email outreach, and telephone engagement. Pricing is not publicly disclosed; no marketplace, reseller, or OEM channels are referenced. The company has built a clinical and academic partner ecosystem that includes AIMS Bibinagar, AIMS Mangalgiri, TIH-IIT Patna, KMIT, Basvatarakam, ZOT Works, Tapadia, and Chest, primarily supporting clinical validation and R&D rather than commercial distribution. Digital Clinic is privately held, founder-owned, and actively fundraising, with no disclosed funding rounds, revenue, headcount, or regulatory clearances in the source material.

Name

Digital Clinic

Legal name

Digital Clinic

Website

https://digitalclinics.co.in

Company type

Private

Founded year

2017

Operating status

Operating

Short description

Digital Clinic is a Hyderabad-based AI healthtech company developing the OncoVision platform for breast cancer pathology grading (Nottingham), BI-RADS screening, and biomarker identification from histology, selling via subscription to Indian hospitals, diagnostic centres, and medical schools.

Ownership category

akta.pro rank

Product category

Medical Imaging AI / Diagnostic Software

NAICS

Medical Laboratories (621511), Computer Systems Design and Related Services (54151), Medical and Diagnostic Laboratories (62151)

SIC

Services-Prepackaged Software (7372), Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Breast Oncology (HLAKAFAJ)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Breast Imaging Centers (Mammography/Tomosynthesis) (HLAFAKAD)

Keywords

• AI medical imaging
• Breast cancer diagnostics
• Radiology AI software
• Diagnostic imaging software
• Cancer detection software

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. AI Diagnostics Platform Licensing: Licensing of OncoVision AI platform to hospitals, diagnostic centres, and medical colleges for breast cancer diagnostics and grading. The platform provides biomarker-based diagnosis to reduce costs and save time.
2. Precision Oncology Services: AI-driven therapy recommendations through biomarkers identification at histology diagnosis, enabling targeted therapy recommendations and faster insurance approvals.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Digital Clinic develops and sells OncoVision (also referenced as DC-OncoVision), an AI-based software platform for breast cancer diagnostics from medical imaging. The platform is sold to hospitals, diagnostic centres, and medical colleges to assist clinicians in detecting and diagnosing breast cancer more accurately and at earlier stages.

Product overview

Digital Clinic offers a unified AI-driven precision diagnostics platform centered on OncoVision (DC-OncoVision), an AI workflow platform for breast cancer diagnostics and grading. The portfolio includes OncoVision as the core AI engine that processes digitized pathology slides and biomarker data for cancer grading and treatment recommendations, supported by specialized diagnostic modules for metastatic breast cancer (with patented Nottingham grading technology) and data-driven ultrasound and mammography imaging. Together, these products enable healthcare professionals to make timely, personalized treatment decisions by combining automated cancer grading (Nottingham/BI-RADS) with clinical biomarker identification and predictive analytics for treatment response.

Differentiator

Problem solved

Functional benefit

Brands

• DC-OncoVision: AI-based workflow platform for breast cancer diagnostics and grading, built to support accurate and efficient decision-making.
• OncoVision

Products and services

• OncoVision (DC-OncoVision) OncoVision (also referenced as DC-OncoVision) is Digital Clinic's AI-powered software platform for breast cancer diagnostics. It analyzes breast imaging studies to assist radiologists and clinicians in detecting and diagnosing breast cancer, and is offered to hospitals, diagnostic centres, and medical colleges.

Quantifiable outcome

• OncoVision's AI-powered analysis delivers results in less than 1 day compared to 3-4 days with traditional methods
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Tih-IIT-PatnacoreStrategic or Co-development PartnerIIT Patna (Tih - Technology Innovation Hub) is a research and development collaborator providing academic and technological expertise for the development of AI-driven digital pathology solutions. The partnership supports the company's R&D capabilities in digital imaging and cancer diagnostics.
• KMITminorStrategic or Co-development PartnerKMIT (KMI Technologies or similar academic institution) collaborates with Digital Clinic, potentially contributing to technology development or validation of AI diagnostics solutions.
• AIMS BibinagarcoreStrategic or Co-development PartnerAIMS (All India Institute of Medical Sciences) Bibinagar is a key clinical collaborator providing institutional validation and clinical data for the company's AI-powered breast cancer diagnostics platform. AIMS institutions serve as reference sites for testing and validating OncoVision.
• AIMS MangalgiricoreStrategic or Co-development PartnerAIMS Mangalgiri is another AIMS institution collaborating with Digital Clinic for clinical validation and testing of the OncoVision platform in real hospital settings.
• BasvatarakamminorStrategic or Co-development PartnerBasvatarakam appears to be a collaborator institution, likely providing clinical or research support for the company's cancer diagnostics initiatives.
• TapadiaminorStrategic or Co-development PartnerTapadia is listed as a collaborator, suggesting involvement in clinical or research partnerships related to Digital Clinic's cancer care solutions.
• ChestminorStrategic or Co-development PartnerChest appears as a collaborator on the Digital Clinic website, likely representing a chest imaging or thoracic diagnostics partnership for the company's AI platform.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Paige AI: Paige AI is a US-based AI digital pathology company developing FDA-authorized computational pathology products for cancer diagnosis, with comparable computer vision and pathology-grade AI capabilities. Directly competes with Digital Clinic in AI-powered cancer diagnostics.
• PathAI: PathAI provides AI-powered pathology solutions for diagnostic and drug development applications, with similar AI pathology grading and biomarker analysis offerings. Direct competitor in AI-enabled cancer pathology workflows.
• Ibex Medical Analytics: Ibex develops AI-based cancer diagnostics for pathology, including breast and other tissue types, deployed across hospital and reference lab networks. Comparable in clinical-grade AI cancer detection and grading.
• Lunit: Lunit is a South Korean AI medical imaging company with FDA-cleared breast cancer screening (Lunit INSIGHT MMG) and pathology products. Direct competitor in mammography AI and oncology workflow tooling.
• Volpara Health: Volpara provides AI-powered breast imaging analytics, including mammography quality assessment and BI-RADS-related tools for hospitals and diagnostic centres. Comparable in AI-driven mammography workflow enhancement.
• iCAD: iCAD develops AI-based breast cancer detection and risk assessment solutions for mammography, deployed in hospital radiology workflows. Comparable in AI mammography screening and breast cancer detection.

Regional players

• Niramai Health Analytix: Niramai is an India-based breast cancer screening startup using AI on thermal imaging for early detection. Comparable as an India-focused AI breast cancer screening company serving hospitals and diagnostic centres.
• Aindra Systems: Aindra is an India-based AI healthcare company building pathology and diagnostics solutions, with comparable AI-driven pathology offerings in the Indian market.
• CARPL.ai: CARPL.ai is an India-based AI radiology platform that integrates multiple AI imaging models into clinical workflows for hospitals and diagnostic centres. Comparable as an India-based AI imaging platform serving similar buyer segments.

Broad incumbents

• Hologic: Hologic is a global medical device company with a dominant breast health franchise (mammography systems, biopsy, diagnostics) including AI capabilities through acquisitions. Operates as a broad incumbent in breast cancer diagnostics that hospitals and diagnostic centres already procure from.

Market position

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/digiclinics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Digital Clinic